CorVista System with PH Add-On vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is a non-invasive diagnostic platform for assessing coronary artery disease and pulmonary hypertension at the point of care. In contrast, Tool B is a remote monitoring platform specifically designed to aggregate and analyze data from cardiac implantable electronic devices for ongoing patient management and workflow optimization. While both serve cardiology, Tool A focuses on initial diagnosis, whereas Tool B specializes in continuous surveillance and management of patients with existing cardiac devices.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
The CorVista System is an FDA-cleared, non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension. In contrast, IM007 is an FDA-cleared, AI-powered, cloud-based platform specifically for remote cardiac monitoring, aggregating data from all cardiac implantable electronic devices (CIEDs).
The CorVista System non-invasively analyzes cardiac and hemodynamic signals at the point of care, requiring no radiation, contrast agents, injections, fasting, or exercise. IM007 aggregates data from existing cardiac implantable electronic devices (CIEDs) from various manufacturers like Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
The CorVista System is designed for patients requiring rapid assessment for coronary artery disease (CAD) and pulmonary hypertension (PH). IM007 is tailored for patients with cardiac implantable electronic devices (CIEDs), aiming to streamline remote monitoring workflows and improve outcomes in cardiology and heart failure management.
The CorVista System utilizes machine-learned algorithms for the rapid assessment of CAD and PH from collected cardiac and hemodynamic signals. IM007 features AI-driven alert management to reduce false positives (e.g., for ILR ECG and AF alerts) and includes SignalHF, an FDA-cleared predictive AI for heart failure hospitalization risk.
The CorVista System provides rapid diagnostic results within minutes via a secure web portal for point-of-care assessment. IM007 offers smart workflow automation for tasks like billing, reporting, and scheduling related to remote monitoring, and includes EHR integration capabilities through a bidirectional API and integration framework.